These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28880187)

  • 1. Integrating Imaging Genomic Data in the Quest for Biomarkers of Schizophrenia Disease.
    Su-Ping Deng ; Wenxing Hu ; Calhoun VD; Yu-Ping Wang
    IEEE/ACM Trans Comput Biol Bioinform; 2018; 15(5):1480-1491. PubMed ID: 28880187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating fMRI and SNP data for biomarker identification for schizophrenia with a sparse representation based variable selection method.
    Cao H; Duan J; Lin D; Calhoun V; Wang YP
    BMC Med Genomics; 2013; 6 Suppl 3(Suppl 3):S2. PubMed ID: 24565219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting schizophrenia by fusing networks from SNPs, DNA methylation and fMRI data.
    Su-Ping Deng ; Dongdong Lin ; Calhoun VD; Yu-Ping Wang
    Annu Int Conf IEEE Eng Med Biol Soc; 2016 Aug; 2016():1447-1450. PubMed ID: 28268598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integration of Imaging (epi)Genomics Data for the Study of Schizophrenia Using Group Sparse Joint Nonnegative Matrix Factorization.
    Wang M; Huang TZ; Fang J; Calhoun VD; Wang YP
    IEEE/ACM Trans Comput Biol Bioinform; 2020; 17(5):1671-1681. PubMed ID: 30762565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating genome-wide association study and methylation functional annotation data identified candidate genes and pathways for schizophrenia.
    Qi X; Guan F; Wen Y; Li P; Ma M; Cheng S; Zhang L; Liang C; Cheng B; Zhang F
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jan; 96():109736. PubMed ID: 31425724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration of SNPs-FMRI-methylation data with sparse multi-CCA for schizophrenia study.
    Wenxing Hu ; Dongdong Lin ; Calhoun VD; Yu-Ping Wang
    Annu Int Conf IEEE Eng Med Biol Soc; 2016 Aug; 2016():3310-3313. PubMed ID: 28269013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel blood-based epigenetic biosignature in first-episode schizophrenia patients through automated machine learning.
    Karaglani M; Agorastos A; Panagopoulou M; Parlapani E; Athanasis P; Bitsios P; Tzitzikou K; Theodosiou T; Iliopoulos I; Bozikas VP; Chatzaki E
    Transl Psychiatry; 2024 Jun; 14(1):257. PubMed ID: 38886359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of CpG SNPs in 34 genes: association test with suicide attempt in schizophrenia.
    Bani-Fatemi A; Gonçalves VF; Zai C; de Souza R; Le Foll B; Kennedy JL; Wong AH; De Luca V
    Schizophr Res; 2013 Jul; 147(2-3):262-8. PubMed ID: 23684163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic influences of resting state fMRI activity in language-related brain regions in healthy controls and schizophrenia patients: a pilot study.
    Jamadar S; Powers NR; Meda SA; Calhoun VD; Gelernter J; Gruen JR; Pearlson GD
    Brain Imaging Behav; 2013 Mar; 7(1):15-27. PubMed ID: 22669497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining fMRI and SNP data to investigate connections between brain function and genetics using parallel ICA.
    Liu J; Pearlson G; Windemuth A; Ruano G; Perrone-Bizzozero NI; Calhoun V
    Hum Brain Mapp; 2009 Jan; 30(1):241-55. PubMed ID: 18072279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An integrative functional genomics approach for discovering biomarkers in schizophrenia.
    Vawter MP; Mamdani F; Macciardi F
    Brief Funct Genomics; 2011 Nov; 10(6):387-99. PubMed ID: 22155586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration analysis of methylation quantitative trait loci and GWAS identify three schizophrenia risk variants.
    Yu H; Cheng W; Zhang X; Wang X; Yue W
    Neuropsychopharmacology; 2020 Jun; 45(7):1179-1187. PubMed ID: 31910432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DRD2 co-expression network and a related polygenic index predict imaging, behavioral and clinical phenotypes linked to schizophrenia.
    Pergola G; Di Carlo P; D'Ambrosio E; Gelao B; Fazio L; Papalino M; Monda A; Scozia G; Pietrangelo B; Attrotto M; Apud JA; Chen Q; Mattay VS; Rampino A; Caforio G; Weinberger DR; Blasi G; Bertolino A
    Transl Psychiatry; 2017 Jan; 7(1):e1006. PubMed ID: 28094815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between DNA methylation and schizophrenia-related intermediate phenotypes - a gene set enrichment analysis.
    Hass J; Walton E; Wright C; Beyer A; Scholz M; Turner J; Liu J; Smolka MN; Roessner V; Sponheim SR; Gollub RL; Calhoun VD; Ehrlich S
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jun; 59():31-39. PubMed ID: 25598502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel Markov Blanket-based repeated-fishing strategy for capturing phenotype-related biomarkers in big omics data.
    Li H; Yuan Z; Ji J; Xu J; Zhang T; Zhang X; Xue F
    BMC Genet; 2016 Mar; 17():51. PubMed ID: 26957081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced cortical thickness related to single nucleotide polymorphisms in the major histocompatibility complex region in antipsychotic-naive schizophrenia.
    Tao B; Xiao Y; Hu N; Shah C; Liu L; Gao X; Liu J; Zhang W; Yao L; Xu H; Hua J; Lui S
    Brain Behav; 2019 May; 9(5):e01253. PubMed ID: 30924326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early onset schizophrenia: Gender analysis of genome-wide potential methylation.
    Bani-Fatemi A; Zai C; De Luca V
    Clin Chim Acta; 2015 Sep; 449():63-7. PubMed ID: 25840049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. nMAGMA: a network-enhanced method for inferring risk genes from GWAS summary statistics and its application to schizophrenia.
    Yang A; Chen J; Zhao XM
    Brief Bioinform; 2021 Jul; 22(4):. PubMed ID: 33230537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of methylation and -141C Ins/Del polymorphisms of the dopamine receptor D2 gene in patients with schizophrenia.
    Funahashi Y; Yoshino Y; Yamazaki K; Ozaki Y; Mori Y; Mori T; Ochi S; Iga JI; Ueno SI
    Psychiatry Res; 2019 Aug; 278():135-140. PubMed ID: 31176829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sparse representation based biomarker selection for schizophrenia with integrated analysis of fMRI and SNPs.
    Cao H; Duan J; Lin D; Shugart YY; Calhoun V; Wang YP
    Neuroimage; 2014 Nov; 102 Pt 1():220-8. PubMed ID: 24530838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.